Publications by authors named "Susan Levinson"

Claim this Profile
L
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.
Sandra Parra, Mireia Saballs, Mark DiNubile, Mireia Feliu, Simona Iftimie, Susan Levinson

Atheroscler Plus· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
Nicole Noren Hooten, Nicolle A Mode, Edward Kowalik, Victor Omoniyi, Alan B Zonderman, Susan L Levinson

J Transl Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.
Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat, Susan L Levinson

Immunohorizons· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.
Mark J DiNubile, Sandra Parra, Antoni Castro Salomó, Susan L Levinson

Open Forum Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of plasma gelsolin with frailty phenotype and mortality among octogenarian community-dwelling men: a cohort study.
Timo E Strandberg, Susan L Levinson, Mark J DiNubile, Satu Jyväkorpi, Mika Kivimäki

Aging Clin Exp Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.
Veena M Bhopale, Deepa Ruhela, Kaighley D Brett, Nathan Z Nugent, Noelle K Fraser, Susan L Levinson

J Appl Physiol (1985)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
John Audley, Emily F Gliniewicz, Kol A Zarember, Hanna S Hong, Gal Wald, Susan L Levinson

Inflammation· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An immune-based biomarker signature is associated with mortality in COVID-19 patients.
Michael S Abers, Ottavia M Delmonte, Emily E Ricotta, Jonathan Fintzi, Danielle L Fink, Susan L Levinson

JCI Insight· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.
Abla Tannous, Susan L Levinson, James Bolognese, Steven M Opal, Mark J DiNubile

Antimicrob Agents Chemother· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pneumonia.
Mark J DiNubile, Susan L Levinson, Thomas P Stossel, Matthew B Lawrenz, Jonathan M Warawa

Open Forum Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza.
Zhiping Yang, Alice Bedugnis, Susan Levinson, Mark DiNubile, Thomas Stossel

F1000Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.
Wesley H Self, Richard G Wunderink, Mark J DiNubile, Thomas P Stossel, Susan L Levinson

Clin Infect Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
Zhiping Yang, Alice Bedugnis, Susan Levinson, Mark Dinubile, Thomas Stossel

J Infect Dis· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of drug development: advancing clinical trial design.
John Orloff, Frank Douglas, Jose Pinheiro, Susan Levinson, Michael Branson

Nat Rev Drug Discov· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis